Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +0.50% |
|
-3.85% | -14.89% |
06-11 | MaxCyte CEO Maher Masoud buys 100,000 shares | AN |
06-11 | Maxcyte Insider Bought Shares Worth $489,066, According to a Recent SEC Filing | MT |
Sales 2024 * | 36.42M 2.88B | Sales 2025 * | 46.63M 3.69B | Capitalization | 426M 33.68B |
---|---|---|---|---|---|
Net income 2024 * | -48M -3.8B | Net income 2025 * | -45M -3.56B | EV / Sales 2024 * | 7.58 x |
Net cash position 2024 * | 150M 11.84B | Net cash position 2025 * | 120M 9.5B | EV / Sales 2025 * | 6.55 x |
P/E ratio 2024 * |
-8.92
x | P/E ratio 2025 * |
-9.67
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.6% |
Latest transcript on MaxCyte, Inc.
1 day | +0.50% | ||
1 week | -3.85% | ||
Current month | -10.71% | ||
1 month | -11.89% | ||
3 months | -7.41% | ||
6 months | -10.51% | ||
Current year | -14.89% |
![Extreme 3.93](/images/extremecours_fleche.png)
![Extreme 3.93](/images/extremecours_fleche.png)
![Extreme 3.57](/images/extremecours_fleche.png)
![Extreme 2.45](/images/extremecours_fleche.png)
![Extreme 2.45](/images/extremecours_fleche.png)
![Extreme 1.63](/images/extremecours_fleche.png)
![Extreme 1.63](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Douglas Swirsky
DFI | Director of Finance/CFO | 54 | 26/03/23 |
James Brady
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Balthrop
BRD | Director/Board Member | 67 | 30/11/22 |
Art Mandell
BRD | Director/Board Member | 71 | 30/04/06 |
Will Brooke
BRD | Director/Board Member | 68 | 29/02/04 |
Date | Price | Change | Volume |
---|---|---|---|
27/06/24 | 4 | +0.50% | 352,592 |
26/06/24 | 3.98 | -2.69% | 449,239 |
25/06/24 | 4.09 | -2.39% | 354,007 |
24/06/24 | 4.19 | -1.18% | 517,688 |
21/06/24 | 4.24 | +1.92% | 651,219 |
Delayed Quote Nasdaq, June 27, 2024 at 09:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.77% | 210B | |
+8.83% | 186B | |
+31.94% | 158B | |
+33.19% | 113B | |
+4.79% | 66.13B | |
+22.41% | 56.25B | |
+1.34% | 49B | |
-5.92% | 38.16B | |
+1.94% | 35.98B |
- Stock Market
- Equities
- MXCT Stock
- MXCT Stock